======= CCL8 =======
== Gene Information ==
* **Official Symbol**: CCL8
* **Official Name**: C-C motif chemokine ligand 8
* **Aliases and Previous Symbols**: N/A
* **Entrez ID**: [[https://www.ncbi.nlm.nih.gov/gene/?term=6355|6355]]
* **UniProt**: [[https://www.uniprot.org/uniprot/P80075|P80075]]
* **Interactions**: [[https://thebiogrid.org/search.php?search=CCL8&organism=9606|BioGRID]]
* **PubMed articles**: [[https://www.ncbi.nlm.nih.gov/pubmed/?term=gene%20CCL8|Open PubMed]]
* **OMIM**: [[https://omim.org/entry/602283|Open OMIM]]
== Function Summary ==
* **Entrez Summary**: N/A
* **UniProt Summary**: Chemotactic factor that attracts monocytes, lymphocytes, basophils and eosinophils. May play a role in neoplasia and inflammatory host responses. This protein can bind heparin. The processed form MCP-2(6-76) does not show monocyte chemotactic activity, but inhibits the chemotactic effect most predominantly of CCL7, and also of CCL2 and CCL5 and CCL8. {ECO:0000269|PubMed:9558113}.
|IL8|
|negative regulation by host of viral genome replication|
|phospholipase activator activity|
|negative regulation by host of viral process|
|modulation by host of viral genome replication|
|eosinophil chemotaxis|
|eosinophil migration|
|modulation by host of viral process|
|CCR chemokine receptor binding|
|monocyte chemotaxis|
|lymphocyte chemotaxis|
|mononuclear cell migration|
|chemokine activity|
|negative regulation of viral genome replication|
|lymphocyte migration|
|modification by host of symbiont morphology or physiology|
|interaction with symbiont|
|negative regulation of leukocyte proliferation|
|chemokine-mediated signaling pathway|
|cell|
|negative regulation of viral life cycle|
|neutrophil chemotaxis|
|granulocyte chemotaxis|
|response to chemokine|
|cellular response to chemokine|
|neutrophil migration|
|regulation of viral genome replication|
|negative regulation of viral process|
|granulocyte migration|
|modification of morphology or physiology of other organism involved in symbiotic interaction|
|myeloid leukocyte migration|
|positive regulation of leukocyte migration|
|leukocyte chemotaxis|
|regulation of viral life cycle|
|modification of morphology or physiology of other organism|
|cellular response to interferon-gamma|
|heparin binding|
|cellular response to interleukin-1|
|response to interferon-gamma|
|regulation of leukocyte migration|
|response to interleukin-1|
|regulation of viral process|
|cell chemotaxis|
|positive regulation of ERK1 and ERK2 cascade|
|negative regulation of multi-organism process|
|regulation of symbiosis, encompassing mutualism through parasitism|
|regulation of leukocyte proliferation|
|protein kinase activity|
|cellular response to tumor necrosis factor|
|calcium ion transport|
|response to tumor necrosis factor|
|response to virus|
|regulation of ERK1 and ERK2 cascade|
|divalent metal ion transport|
|divalent inorganic cation transport|
|leukocyte migration|
|positive regulation of GTPase activity|
|cellular calcium ion homeostasis|
|calcium ion homeostasis|
|cellular divalent inorganic cation homeostasis|
|regulation of GTPase activity|
|divalent inorganic cation homeostasis|
|inflammatory response|
|positive regulation of cell migration|
|positive regulation of cell motility|
|positive regulation of cellular component movement|
|positive regulation of MAPK cascade|
|chemotaxis|
|taxis|
|positive regulation of locomotion|
|cellular metal ion homeostasis|
|metal ion homeostasis|
|cellular cation homeostasis|
|metal ion transport|
|cellular ion homeostasis|
|cytokine-mediated signaling pathway|
|negative regulation of cell population proliferation|
|cation homeostasis|
|inorganic ion homeostasis|
|cellular chemical homeostasis|
|regulation of MAPK cascade|
|innate immune response|
|positive regulation of hydrolase activity|
|regulation of multi-organism process|
|symbiotic process|
|ion homeostasis|
|exocytosis|
|interspecies interaction between organisms|
|cation transport|
|regulation of cell migration|
|cellular homeostasis|
|regulation of cell motility|
|defense response to other organism|
|cell migration|
|protein phosphorylation|
|regulation of locomotion|
|regulation of cellular component movement|
|secretion by cell|
|cellular response to cytokine stimulus|
|positive regulation of protein phosphorylation|
|positive regulation of intracellular signal transduction|
|export from cell|
|positive regulation of phosphorylation|
|cell motility|
|localization of cell|
|response to cytokine|
|chemical homeostasis|
|cell-cell signaling|
|secretion|
|positive regulation of phosphorus metabolic process|
|positive regulation of phosphate metabolic process|
|positive regulation of immune system process|
|positive regulation of protein modification process|
|regulation of hydrolase activity|
|phosphorylation|
|response to other organism|
|response to external biotic stimulus|
|locomotion|
|G protein-coupled receptor signaling pathway|
|response to biotic stimulus|
|defense response|
|ion transport|
|positive regulation of catalytic activity|
|regulation of protein phosphorylation|
|movement of cell or subcellular component|
|regulation of phosphorylation|
|extracellular space|
|positive regulation of cellular protein metabolic process|
|regulation of cell population proliferation|
|homeostatic process|
|regulation of immune system process|
|positive regulation of signal transduction|
|positive regulation of protein metabolic process|
|positive regulation of molecular function|
|regulation of phosphate metabolic process|
|regulation of phosphorus metabolic process|
|positive regulation of cell communication|
|positive regulation of signaling|
|regulation of intracellular signal transduction|
|regulation of protein modification process|
|immune response|
|vesicle-mediated transport|
\\
=== CRISPR Data ===
^Screen^Score^
|[[:results:exp441|GSK-J4 1.5μM R08 exp441]]|-1.85|
|[[:results:exp410|THZ531 0.11 to 0.125μM on day4 R07 exp410]]|1.7|
|[[:results:exp409|THZ531 0.11μM R07 exp409]]|1.72|
|[[:results:exp341|BRD2 inhibitor II 20μM R07 exp341]]|1.83|
|[[:results:exp405|Tenofovir 10μM R07 exp405]]|2.19|
No correlation found to any other genes in chemogenomics.
Global Fraction of Cell Lines Where Essential: 0/739
^Tissue^Fraction Of Cell Lines Where Essential^
|1290807.0|0/1|
|909776.0|0/1|
|bile duct|0/28|
|blood|0/28|
|bone|0/26|
|breast|0/33|
|central nervous system|0/56|
|cervix|0/4|
|colorectal|0/17|
|esophagus|0/13|
|fibroblast|0/1|
|gastric|0/16|
|kidney|0/21|
|liver|0/20|
|lung|0/75|
|lymphocyte|0/16|
|ovary|0/26|
|pancreas|0/24|
|peripheral nervous system|0/16|
|plasma cell|0/15|
|prostate|0/1|
|skin|0/24|
|soft tissue|0/9|
|thyroid|0/2|
|upper aerodigestive|0/22|
|urinary tract|0/29|
|uterus|0/5|
== Essentiality in NALM6 ==
* **Essentiality Rank**: 18676
* **Expression level (log2 read counts)**: -6.6
{{:chemogenomics:nalm6 dist.png?nolink |}}